Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph phase_3
1
9%
Ph phase_4
4
36%
Ph not_applicable
3
27%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(5)

Detailed Status

unknown5
Completed4
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 44 (44.4%)
N/A3 (33.3%)

Trials by Status

withdrawn19%
recruiting19%
unknown545%
completed436%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11